New regimens of benznidazole for the treatment of chronic Chagas disease in adult participants in indeterminate form or with mild cardiac progression (NuestroBen study): protocol for a phase III randomised, multicentre non-inferiority clinical trial.

Marques T, Forsyth C, Barreira F, Lombas C, Blum de Oliveira B, Laserna M, Molina I, Bangher MDC, Javier Fernández R, Lloveras S, Fernández ML, Scapellato P, Patterson P, Garcia W, Ortiz L, Schijman A, Moreira OC, García L, Viele K, Longhi S, Vaillant M, Tipple C, Fraisse L, Silvestre-Sousa A, Sosa-Estani S, Pinazo MJ

Open source

DOI
10.1136/bmjopen-2024-098079
Published
2025 Sep 30
Container
BMJ open
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1136/bmjopen-2024-098079,
  title = {New regimens of benznidazole for the treatment of chronic Chagas disease in adult participants in indeterminate form or with mild cardiac progression (NuestroBen study): protocol for a phase III randomised, multicentre non-inferiority clinical trial.},
  author = {Marques T and Forsyth C and Barreira F and Lombas C and Blum de Oliveira B and Laserna M and Molina I and Bangher MDC and Javier Fernández R and Lloveras S and Fernández ML and Scapellato P and Patterson P and Garcia W and Ortiz L and Schijman A and Moreira OC and García L and Viele K and Longhi S and Vaillant M and Tipple C and Fraisse L and Silvestre-Sousa A and Sosa-Estani S and Pinazo MJ},
  year = {2025},
  journal = {BMJ open},
  doi = {10.1136/bmjopen-2024-098079},
  url = {https://doi.org/10.1136/bmjopen-2024-098079}
}

RIS

TY  - JOUR
TI  - New regimens of benznidazole for the treatment of chronic Chagas disease in adult participants in indeterminate form or with mild cardiac progression (NuestroBen study): protocol for a phase III randomised, multicentre non-inferiority clinical trial.
AU  - Marques T
AU  - Forsyth C
AU  - Barreira F
AU  - Lombas C
AU  - Blum de Oliveira B
AU  - Laserna M
AU  - Molina I
AU  - Bangher MDC
AU  - Javier Fernández R
AU  - Lloveras S
AU  - Fernández ML
AU  - Scapellato P
AU  - Patterson P
AU  - Garcia W
AU  - Ortiz L
AU  - Schijman A
AU  - Moreira OC
AU  - García L
AU  - Viele K
AU  - Longhi S
AU  - Vaillant M
AU  - Tipple C
AU  - Fraisse L
AU  - Silvestre-Sousa A
AU  - Sosa-Estani S
AU  - Pinazo MJ
PY  - 2025
JO  - BMJ open
DO  - 10.1136/bmjopen-2024-098079
UR  - https://doi.org/10.1136/bmjopen-2024-098079
ER  - 

APA

T, M., C, F., F, B., C, L., B, B. D. O., M, L., I, M., MDC, B., R, J. F., S, L., ML, F., P, S., P, P., W, G., L, O., A, S., OC, M., L, G., K, V., S, L., M, V., C, T., L, F., A, S., S, S., & MJ, P. (2025). New regimens of benznidazole for the treatment of chronic Chagas disease in adult participants in indeterminate form or with mild cardiac progression (NuestroBen study): protocol for a phase III randomised, multicentre non-inferiority clinical trial.. BMJ open. https://doi.org/10.1136/bmjopen-2024-098079

Source records